Advertisement

Topics

Advocates Worry GOP’s Plan To Cut Orphan Drug Tax Credit Will Hurt Patients

08:54 EST 13 Nov 2017 | Kaiser Health News

The credit reimburses drug developers for half of their research costs on treatments meant for diseases with patient populations fewer than 200,000 people.

Original Article: Advocates Worry GOP’s Plan To Cut Orphan Drug Tax Credit Will Hurt Patients

NEXT ARTICLE

More From BioPortfolio on "Advocates Worry GOP’s Plan To Cut Orphan Drug Tax Credit Will Hurt Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...